attaching a phenotype or disease code up front may be misleading.
Point was raised that care needs to be taken to ensure that the value of the relevance field in the current model is not misconstrued as the disease or phenotype against which the model is validated for clinical use.
There was also a good point raised on the call that it is better to provide the author intent about disease/phenotype relevance at submission, such that MAVE data are assessed in the context of how the authors envisioned they would be useful.
It may be worth documenting the distinction between the role of the broader minimum information standard and associated data schemas from the specific case of the downstream clinical workflows they may be used in.
Discussion topic raised on 2/20 CVI call.
Point was raised that care needs to be taken to ensure that the value of the relevance field in the current model is not misconstrued as the disease or phenotype against which the model is validated for clinical use.
There was also a good point raised on the call that it is better to provide the author intent about disease/phenotype relevance at submission, such that MAVE data are assessed in the context of how the authors envisioned they would be useful.
It may be worth documenting the distinction between the role of the broader minimum information standard and associated data schemas from the specific case of the downstream clinical workflows they may be used in.